Insider Transactions in Q4 2020 at Kinnate Biopharma Inc. (KNTE)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 07
2020
|
James B. Tananbaum |
BUY
Conversion of derivative security
|
Indirect |
9,838,311
+40.47%
|
-
|
|
Dec 07
2020
|
Carl L Gordon Director |
BUY
Conversion of derivative security
|
Indirect |
3,097,929
+27.66%
|
-
|
|
Dec 07
2020
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
3,097,929
+27.66%
|
-
|
|
Dec 07
2020
|
Foresite Capital Management Iv, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
9,838,311
+40.47%
|
-
|
|
Dec 03
2020
|
James B. Tananbaum |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+50.0%
|
$20,000,000
$20.0 P/Share
|
|
Dec 03
2020
|
Foresite Capital Management Iv, LLC > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
1,000,000
+50.0%
|
$20,000,000
$20.0 P/Share
|
|
Dec 02
2020
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
750,000
+50.0%
|
$15,000,000
$20.0 P/Share
|
|
Dec 02
2020
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
750,000
+50.0%
|
$15,000,000
$20.0 P/Share
|